Analysts See $-0.12 EPS for Azure Power Global Limited (AZRE); Shorts at Catalent (CTLT) Raised By 21.1%

Catalent, Inc. (NYSE:CTLT) Logo

Analysts expect Azure Power Global Limited (NYSE:AZRE) to report $-0.12 EPS on February, 14.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.12 EPS. After having $-0.03 EPS previously, Azure Power Global Limited’s analysts see 300.00% EPS growth. The stock decreased 1.19% or $0.11 during the last trading session, reaching $8.73. About 5,647 shares traded. Azure Power Global Limited (NYSE:AZRE) has declined 25.75% since January 14, 2018 and is downtrending. It has underperformed by 25.75% the S&P500. Some Historical AZRE News: 31/05/2018 – AZURE POWER – INVESTMENT TO FACILITATE DEVELOPMENT OF ABOUT 200 MWS OF AZURE ROOF POWER PROJECTS; 21/03/2018 Azure Power Wins 130 MWs of Solar Power Projects; 22/05/2018 – Azure Power Marks New Milestone with the Crossing of 2 Gigawatt Solar Portfolio; 15/05/2018 – Azure Power Surpasses 1 GW of Operating Solar Capacity; 03/04/2018 – Azure Power Wins 200 MW Solar Power Project in Gujarat; 22/05/2018 – AZURE POWER – PORTFOLIO CROSSED 2 GW MILESTONE BY WINNING FOUR 50 MW PROJECTS FOR A CUMULATIVE CAPACITY OF 200 MWS IN STATE OF MAHARASHTRA; 17/05/2018 – Azure Power Wins 130 MW Solar Power Project in Maharashtra; 24/05/2018 – Azure Power Headquarter Receives India’s First and Highest Rated Platinum Certification under LEED v4 Commercial Interiors; 17/04/2018 – Azure Power Commissions 40 MW Project in Uttar Pradesh; 24/05/2018 – Azure Power Headquarter Receives lndia‚Äôs First and Highest Rated Platinum Certification under LEED v4 Commercial lnteriors

Catalent Inc (NYSE:CTLT) had an increase of 21.1% in short interest. CTLT’s SI was 3.76M shares in January as released by FINRA. Its up 21.1% from 3.10M shares previously. With 1.52 million avg volume, 3 days are for Catalent Inc (NYSE:CTLT)’s short sellers to cover CTLT’s short positions. The stock decreased 0.56% or $0.19 during the last trading session, reaching $33.56. About 435,652 shares traded. Catalent, Inc. (NYSE:CTLT) has declined 9.25% since January 14, 2018 and is downtrending. It has underperformed by 9.25% the S&P500. Some Historical CTLT News: 01/05/2018 – Catalent 3Q Rev $627.9M; 01/05/2018 – Catalent Sees FY18 Adj Net $212M-$232M; 01/05/2018 – CATALENT 3Q ADJ EPS 41C, EST. 39C; 23/04/2018 – BLACKMORES LTD – ACQUIRED CATALENT AUSTRALIA TABLET AND SOFT-GEL CAPSULE MANUFACTURING FACILITY IN VICTORIA FOR $43.2 MLN; 24/04/2018 – Catalent Closes Below 50-Day Moving Average: Technicals; 01/05/2018 – CATALENT REAFFIRMS FY ’18 GUIDANCE; 05/04/2018 – Federal Register: Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC; 03/05/2018 – Catalent Closes Below 200-Day Moving Average: Technicals; 01/05/2018 – Catalent Sees FY18 Capex $152M-$165M; 21/04/2018 – DJ Catalent Inc, Inst Holders, 1Q 2018 (CTLT)

Since September 13, 2018, it had 2 insider purchases, and 3 selling transactions for $7.24 million activity. Another trade for 13,000 shares valued at $488,930 was made by GREISCH JOHN J on Thursday, November 8. 130,545 Catalent, Inc. (NYSE:CTLT) shares with value of $5.92 million were sold by Chiminski John R. Another trade for 47,265 shares valued at $1.97 million was made by Littlejohns Barry on Monday, October 15. The insider Miyamoto Lance sold $277,313. MOREL DONALD E JR had bought 10,000 shares worth $430,000 on Thursday, September 13.

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. The company has market cap of $4.88 billion. It operates through three divisions: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. It has a 69.63 P/E ratio. The Softgel Technologies segment offers formulation, development, and manufacturing services for softgels, which are used in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics.

More news for Catalent, Inc. (NYSE:CTLT) were recently published by:, which released: “Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities – Business Wire” on January 07, 2019.‘s article titled: “Catalent FQ1 miss pressures shares, down 14% – Seeking Alpha” and published on November 06, 2018 is yet another important article.

Among 2 analysts covering Catalent (NYSE:CTLT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Catalent had 2 analyst reports since August 29, 2018 according to SRatingsIntel. The stock has “Outperform” rating by First Analysis on Wednesday, November 7. The firm has “Overweight” rating by JP Morgan given on Wednesday, August 29.

Investors sentiment increased to 1.54 in Q3 2018. Its up 0.54, from 1 in 2018Q2. It increased, as 19 investors sold Catalent, Inc. shares while 73 reduced holdings. 43 funds opened positions while 99 raised stakes. 134.80 million shares or 6.84% more from 126.16 million shares in 2018Q2 were reported. Brinker Cap reported 0.06% in Catalent, Inc. (NYSE:CTLT). Aristotle Cap Boston Limited holds 0.18% or 53,951 shares in its portfolio. Northern Trust reported 1.10 million shares stake. Ent Serv reported 83 shares. Hartford Inv Management reported 0.01% stake. The Oregon-based Oregon Public Employees Retirement Fund has invested 0.04% in Catalent, Inc. (NYSE:CTLT). Daruma Ltd Liability Corp has 109,566 shares for 0.47% of their portfolio. New York-based Tiaa Cref Invest Ltd has invested 0.02% in Catalent, Inc. (NYSE:CTLT). 80,520 were accumulated by Fiera. Foundry Prns Limited Liability Com invested 0.07% of its portfolio in Catalent, Inc. (NYSE:CTLT). The California-based California Pub Employees Retirement Systems has invested 0.01% in Catalent, Inc. (NYSE:CTLT). Texas Permanent School Fund invested in 0.06% or 91,155 shares. Norris Perne & French Limited Liability Partnership Mi holds 1.23% of its portfolio in Catalent, Inc. (NYSE:CTLT) for 206,692 shares. Connable Office owns 9,878 shares or 0.09% of their US portfolio. State Board Of Administration Of Florida Retirement Systems reported 0.02% in Catalent, Inc. (NYSE:CTLT).

More notable recent Azure Power Global Limited (NYSE:AZRE) news were published by: which released: “Biotech to create 170 jobs, invest $28M in new Rockville HQ – Washington Business Journal” on January 14, 2019, also with their article: “Market Outlook: Short-Term Momentum And Long-Term Risks – Seeking Alpha” published on January 12, 2019, published: “3 Big Stock Charts for Thursday: McCormick & Co, Verizon and Alexandria Real Estate Equities –” on December 20, 2018. More interesting news about Azure Power Global Limited (NYSE:AZRE) were released by: and their article: “Cambridge drug developer Tiburio launches, targeting pituitary tumors with $31M – Boston Business Journal” published on January 03, 2019 as well as‘s news article titled: “Alexandria plans large South Boston life science facility – Boston Business Journal” with publication date: December 18, 2018.

Azure Power Global Limited, together with its subsidiaries, engages in the development, construction, ownership, operation, maintenance, and management of solar power plants in India. The company has market cap of $357.61 million. It generates solar energy based on long-term contracts with Indian government entities, as well as other non-governmental energy distribution companies and commercial customers. It currently has negative earnings. As of March 31, 2017, it had an installed capacity of 12.2 gigawatts.

Catalent, Inc. (NYSE:CTLT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.